Van Roy, N., De Preter, K., Hoebeeck, J., Van Maerken, T., Pattyn, F., Mestdagh, P., . . . Speleman, F. (2009). The emerging molecular pathogenesis of neuroblastoma: Implications for improved risk assessment and targeted therapy. BioMed Central.

Van Roy, Nadine, Katleen De Preter, Jasmien Hoebeeck, Tom Van Maerken, Filip Pattyn, Pieter Mestdagh, Joëlle Vermeulen, Jo Vandesompele, und Frank Speleman. The Emerging Molecular Pathogenesis of Neuroblastoma: Implications for Improved Risk Assessment and Targeted Therapy. BioMed Central, 2009.

Van Roy, Nadine, et al. The Emerging Molecular Pathogenesis of Neuroblastoma: Implications for Improved Risk Assessment and Targeted Therapy. BioMed Central, 2009.